| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.27 | 1e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |